288 related articles for article (PubMed ID: 30338719)
1. Co-delivery of deferoxamine and hydroxysafflor yellow A to accelerate diabetic wound healing via enhanced angiogenesis.
Gao SQ; Chang C; Li JJ; Li Y; Niu XQ; Zhang DP; Li LJ; Gao JQ
Drug Deliv; 2018 Nov; 25(1):1779-1789. PubMed ID: 30338719
[TBL] [Abstract][Full Text] [Related]
2. Topical application of Hydroxysafflor Yellow A accelerates the wound healing in streptozotocin induced T1DM rats.
Gao SQ; Chang C; Niu XQ; Li LJ; Zhang Y; Gao JQ
Eur J Pharmacol; 2018 Mar; 823():72-78. PubMed ID: 29408092
[TBL] [Abstract][Full Text] [Related]
3. Transdermal deferoxamine prevents pressure-induced diabetic ulcers.
Duscher D; Neofytou E; Wong VW; Maan ZN; Rennert RC; Inayathullah M; Januszyk M; Rodrigues M; Malkovskiy AV; Whitmore AJ; Walmsley GG; Galvez MG; Whittam AJ; Brownlee M; Rajadas J; Gurtner GC
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):94-9. PubMed ID: 25535360
[TBL] [Abstract][Full Text] [Related]
4. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.
Hou Z; Nie C; Si Z; Ma Y
Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275
[TBL] [Abstract][Full Text] [Related]
5. Optimization of transdermal deferoxamine leads to enhanced efficacy in healing skin wounds.
Duscher D; Trotsyuk AA; Maan ZN; Kwon SH; Rodrigues M; Engel K; Stern-Buchbinder ZA; Bonham CA; Barrera J; Whittam AJ; Hu MS; Inayathullah M; Rajadas J; Gurtner GC
J Control Release; 2019 Aug; 308():232-239. PubMed ID: 31299261
[TBL] [Abstract][Full Text] [Related]
6. Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound.
Chen H; Jia P; Kang H; Zhang H; Liu Y; Yang P; Yan Y; Zuo G; Guo L; Jiang M; Qi J; Liu Y; Cui W; Santos HA; Deng L
Adv Healthc Mater; 2016 Apr; 5(8):907-18. PubMed ID: 26891197
[TBL] [Abstract][Full Text] [Related]
7. Deferoxamine can prevent pressure ulcers and accelerate healing in aged mice.
Bonham CA; Rodrigues M; Galvez M; Trotsyuk A; Stern-Buchbinder Z; Inayathullah M; Rajadas J; Gurtner GC
Wound Repair Regen; 2018 May; 26(3):300-305. PubMed ID: 30152571
[TBL] [Abstract][Full Text] [Related]
8. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
Jia P; Chen H; Kang H; Qi J; Zhao P; Jiang M; Guo L; Zhou Q; Qian ND; Zhou HB; Xu YJ; Fan Y; Deng LF
J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768
[TBL] [Abstract][Full Text] [Related]
9. Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats.
Mehrabani M; Najafi M; Kamarul T; Mansouri K; Iranpour M; Nematollahi MH; Ghazi-Khansari M; Sharifi AM
Cell Prolif; 2015 Oct; 48(5):532-49. PubMed ID: 26332145
[TBL] [Abstract][Full Text] [Related]
10. Bioactive Injectable Hydrogels Containing Desferrioxamine and Bioglass for Diabetic Wound Healing.
Kong L; Wu Z; Zhao H; Cui H; Shen J; Chang J; Li H; He Y
ACS Appl Mater Interfaces; 2018 Sep; 10(36):30103-30114. PubMed ID: 30113159
[TBL] [Abstract][Full Text] [Related]
11. A novel matrix metalloproteinases-cleavable hydrogel loading deferoxamine accelerates diabetic wound healing.
Li N; Zhan A; Jiang Y; Liu H
Int J Biol Macromol; 2022 Dec; 222(Pt A):1551-1559. PubMed ID: 36155786
[TBL] [Abstract][Full Text] [Related]
12. Deferoxamine enhances the regenerative potential of diabetic Adipose Derived Stem Cells.
Hopfner U; Maan ZN; Hu MS; Aitzetmüller MM; Zaussinger M; Kirsch M; Machens HG; Duscher D
J Plast Reconstr Aesthet Surg; 2020 Sep; 73(9):1738-1746. PubMed ID: 32418841
[TBL] [Abstract][Full Text] [Related]
13. Deferoxamine: An Angiogenic and Antioxidant Molecule for Tissue Regeneration.
Holden P; Nair LS
Tissue Eng Part B Rev; 2019 Dec; 25(6):461-470. PubMed ID: 31184273
[TBL] [Abstract][Full Text] [Related]
14. Glucose-responsive multifunctional metal-organic drug-loaded hydrogel for diabetic wound healing.
Yang J; Zeng W; Xu P; Fu X; Yu X; Chen L; Leng F; Yu C; Yang Z
Acta Biomater; 2022 Mar; 140():206-218. PubMed ID: 34879294
[TBL] [Abstract][Full Text] [Related]
15. Calcium ion cross-linked sodium alginate hydrogels containing deferoxamine and copper nanoparticles for diabetic wound healing.
Li S; Wang X; Chen J; Guo J; Yuan M; Wan G; Yan C; Li W; Machens HG; Rinkevich Y; Yang X; Song H; Chen Z
Int J Biol Macromol; 2022 Mar; 202():657-670. PubMed ID: 35066024
[TBL] [Abstract][Full Text] [Related]
16. Local injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expression.
Wang C; Cai Y; Zhang Y; Xiong Z; Li G; Cui L
PLoS One; 2014; 9(6):e100818. PubMed ID: 24963878
[TBL] [Abstract][Full Text] [Related]
17. Lecithin-based deferoxamine nanoparticles accelerated cutaneous wound healing in diabetic rats.
Qayoom A; Aneesha VA; Anagha S; Dar JA; Kumar P; Kumar D
Eur J Pharmacol; 2019 Sep; 858():172478. PubMed ID: 31228457
[TBL] [Abstract][Full Text] [Related]
18. Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats.
Ram M; Singh V; Kumawat S; Kumar D; Lingaraju MC; Uttam Singh T; Rahal A; Kumar Tandan S; Kumar D
Eur J Pharmacol; 2015 Oct; 764():9-21. PubMed ID: 26101070
[TBL] [Abstract][Full Text] [Related]
19. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
[TBL] [Abstract][Full Text] [Related]
20. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
